{
  "id": 573945,
  "title": "Chasing Dupixent, a biotech aims to make better antibody drugs for eczema",
  "url": "https://urgent.news/2026/08/11/chasing-dupixent-a-biotech-aims-to-make-better-antibody-drugs-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-11T13:40:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/infinimmune-atopic-dermatitis-series-a-financing-dupixent/827504/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}